Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
10/2000
10/26/2000WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands
10/26/2000WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
10/26/2000WO2000004012A9 COMPOUNDS SPECIFIC FOR THE HUMAN α1d ADRENERGIC RECEPTOR AND USES THEREOF
10/26/2000DE19918211A1 New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
10/26/2000CA2370417A1 Substituted azoles
10/26/2000CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000CA2370129A1 Methods and compositions for modulating an immune response
10/26/2000CA2370127A1 Novel method of treatment
10/26/2000CA2367395A1 Cyclic amine derivatives and use thereof
10/26/2000CA2367359A1 Dibenzoazulene derivatives for the treatment of thrombosis, osteoporosis, arteriosclerosis
10/26/2000CA2367356A1 New compounds, their preparation and use
10/25/2000EP1046410A2 Calcium and magnesium containing phosphate binding agent for the treatment of hyperphosphatemia
10/25/2000EP1045846A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
10/25/2000EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
10/25/2000CN1271349A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/25/2000CN1057760C Amino acid substituted benzoylguanidines, process for their preparation, their use and medicament containing them
10/24/2000US6136861 Bicyclo[2.2.1]heptanes and related compounds
10/24/2000US6136843 Indole derivatives useful as endothelin receptor antagonists
10/24/2000US6136842 Sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
10/24/2000US6136839 Using a sulfone or sulfoamide benzene compound
10/24/2000US6136828 Endothelin receptor antagonists
10/24/2000US6136792 Prostate specific enhancer polynucleotides and methods of use thereof
10/24/2000US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
10/24/2000US6136563 With defined substitutions for enhanced affinity for its receptor
10/19/2000WO2000061788A2 Poly(dipeptide) as a drug carrier
10/19/2000WO2000061774A2 Bone morphogenic proteins
10/19/2000WO2000061757A1 Tumor necrosis factor homologs and nucleic acids encoding the same
10/19/2000WO2000061750A2 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS
10/19/2000WO2000061746A1 13 transmembrane protein expressed in prostate cancer
10/19/2000WO2000061637A1 Erythropoietin receptor antibodies
10/19/2000WO2000061622A2 Genes associated with diseases of the kidney
10/19/2000WO2000061620A1 49 human secreted proteins
10/19/2000WO2000061608A2 Low-molecular inhibitors of complement proteases
10/19/2000WO2000061604A2 Pharmaceutical compounds
10/19/2000WO2000061579A1 New endothelin converting enzyme inhibitors, their production and their use
10/19/2000WO2000061576A1 Triarylimidazoles
10/19/2000WO2000061554A1 1-amino ethylindole derivatives for the treatment of urinary incontinence
10/19/2000WO2000061553A1 2-aminoethyl-indole derivatives, their preparation and therapeutic use
10/19/2000WO2000061551A2 Pyrimidine-2-one derivatives as integrin receptor ligands
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000061180A2 Products and methods for treating ptp lar related diseases
10/19/2000WO2000061174A2 Use of pegylated interferon alpha for renal cell carcinoma treatment
10/19/2000WO2000061135A1 Method for the treatment of incontinence
10/19/2000WO2000061121A2 Use of molecular weight-amplified hirudin as an anticoagulant in extracorporeal renal replacement therapy
10/19/2000WO2000041505A3 Anthranilic acid derivatives
10/19/2000WO2000013702A9 Use of an angiogenic factor for the treatment of microvascular angiopathies
10/19/2000WO2000012720A8 Elongase genes and uses thereof
10/19/2000DE19917505A1 Treating cytokine-mediated diseases, e.g. asthma, allergy, eczema, rheumatoid arthritis or transplant rejection, using new or known maduraphthalazine derivatives
10/19/2000DE19916837A1 New di- or tetrahydro-benzoazulene derivatives, are integrin inhibitors useful e.g. for treating thrombosis, coronary heart disease, arteriosclerosis, tumors, osteoporosis or rheumatoid arthritis
10/19/2000DE19916719A1 Neue ECE-Inhibitoren, ihre Herstellung und Verwendung New ECE inhibitors, their preparation and use
10/19/2000DE19915602A1 3-Amino-4-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-4-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000DE19915601A1 3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung 3-amino-3-arylpropan-1-ol-derivatives, their preparation and use
10/19/2000CA2370767A1 49 human secreted proteins
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/19/2000CA2369413A1 Transmembrane protein expressed in prostate and other cancers
10/19/2000CA2369378A1 Low-molecular inhibitors of complement proteases
10/19/2000CA2369096A1 Use of increased-molecular-weight hirudin as an anticoagulant in extracorporeal kidney replacement therapy
10/19/2000CA2369029A1 Poly(dipeptide) as a drug carrier
10/19/2000CA2368049A1 Integrin receptor ligands
10/19/2000CA2365945A1 Products and methods for treating ptp lar related diseases
10/19/2000CA2365917A1 Bone morphogenic proteins
10/19/2000CA2365913A1 Tumor necrosis factor receptor homologs and nucleic acids encoding the same
10/19/2000CA2365623A1 Tyrosine kinase substrate (tks) proteins
10/19/2000CA2364541A1 Genes associated with diseases of the kidney
10/19/2000CA2362026A1 Method for the treatment of incontinence
10/18/2000EP1044206A1 Prodrugs of naaladase inhibitors
10/18/2000EP1044200A1 Preparation of terazosin hydrochloride dihydrate
10/18/2000EP1044008A1 Use of aliphatic polyamines for reducing oxalate
10/18/2000EP1043993A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents
10/18/2000EP1043992A2 $i(R)-PROCYCLIDINE FOR TREATING URINARY INCONTINENCE
10/18/2000CN1270585A Substituted 1,2,3,4-tetrahydronaphthalene derivatives
10/18/2000CN1270527A Use of neurotoxin therapy for treatment of urologic and related disorders
10/18/2000CN1270518A Therapeutic or prophylactic agent for glomerulopathy
10/18/2000CN1270163A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270162A 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
10/18/2000CN1270054A Chinese patent medicine for treating prostatic diseases
10/18/2000CN1270027A Stable aqueous solution of phthalylglutamic acidimide derivative
10/18/2000CN1057465C Medicine for treating chronic kidney disease and its prepn. method
10/18/2000CN1057453C Tongniaoling for diuresis
10/17/2000US6133319 For treating an interleukin-8 (il-8) mediated disease by administering a phenyl urea or phenyl thiourea of given formula, such as n-cyclohexyl-n'-(2-hydroxy-4-nitrophenyl)urea
10/17/2000US6133272 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
10/17/2000US6133269 Polymorphic form of doxazosin mesylate (form II)
10/17/2000US6133267 Use of 2-(2-morpholinophenyl) guanidine derivatives for the treatment of diabetes complications
10/17/2000CA2305893A1 Use of maduraphthalazine derivatives as inhibitors of proinflammatory cytokines
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059946A1 Hydroxymatairesinol in cancer prevention
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059904A2 Compounds and methods to treat cardiac failure and other disorders
10/12/2000WO2000059886A2 Benzimidazole abd imidazolophyridine derivaties, their preparation and their use as selective modulators of bradykinin b2 (=bk-2) receptors
10/12/2000WO2000059875A2 Novel inhibitors of formation of advanced glycation endproducts (age's)
10/12/2000WO2000059855A1 Ether compounds, compositions, and uses thereof
10/12/2000WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
10/12/2000WO2000059525A2 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES
10/12/2000WO2000059520A1 Herbal compositions and uses for the treatment of allergic reactions
10/12/2000WO2000059509A1 Phthalazine derivatives for treating inflammatory diseases
10/12/2000WO2000059493A2 Improved dialysis solutions and methods
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
1 ... 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 ... 562